Subscribe to RSS
DOI: 10.1055/s-2007-982556
A Stereoselective Synthesis of the C20-C32 Fragment of the Phorboxazoles
Publication History
Publication Date:
06 June 2007 (online)
Abstract
The C20-C32 fragment of the phorboxazoles was realized in a stereoconvergent manner utilizing a desymmetrization approach. This successful strategy involves epimerization and modified Julia olefination as key steps.
Keywords
phorboxazole - desymmetrization - epimerization - Julia olefination
-
1a
Searle PA.Molinski TF. J. Am. Chem. Soc. 1995, 117: 8126 -
1b
Searle PA.Molinski TF.Brzezinski LJ.Leahy JW. J. Am. Chem. Soc. 1996, 118: 9422 -
1c
Molinski TF. Tetrahedron Lett. 1996, 37: 7879 -
2a
Ye T.Pattenden G. Tetrahedron Lett. 1998, 39: 319 -
2b
Pattenden G.Plowright AT.Tornos JA.Ye T. Tetrahedron Lett. 1998, 39: 6099 -
2c
Paterson I.Arnott EA. Tetrahedron Lett. 1998, 39: 7185 -
2d
Williams DR.Clark MP.Berliner MA. Tetrahedron Lett. 1999, 40: 2287 -
2e
Williams DR.Clark MP. Tetrahedron Lett. 1999, 40: 2291 -
2f
Wolbers P.Misske AM.Hoffmann HMR. Tetrahedron Lett. 1999, 40: 4527 -
2g
Wolbers P.Hoffmann HMR. Synthesis 1999, 797 -
2h
Wolbers P.Hoffmann HMR. Tetrahedron 1999, 55: 1905 -
2i
Misske AM.Hoffmann HMR. Tetrahedron 1999, 55: 4315 -
2j
Rychnovsky SD.Thomas CR. Org. Lett. 2000, 2: 1217 -
2k
Donaldson WA.Greer PB. Tetrahedron Lett. 2000, 41: 3801 -
2l
Huang H.Panek JS. Org. Lett. 2001, 3: 1693 -
2m
González MA.Pattenden G. Angew. Chem. Int. Ed. 2003, 42: 1255 -
2n
Paterson I.Luckhurst CA. Tetrahedron Lett. 2003, 44: 3749 -
2o
Chakraborty TK.Reddy VR.Reddy TJ. Tetrahedron 2003, 59: 8613 -
3a
Forsyth CJ.Ahmed F.Cink RD.Lee CS. J. Am. Chem. Soc. 1998, 120: 5597 -
3b
Evans DA.Fitch DM.Smith TE.Cee VJ. J. Am. Chem. Soc. 2000, 122: 10033 -
3c
Smith AB.Minbiole KP.Verhoest PR.Schelhaas M. J. Am. Chem. Soc. 2001, 123: 10942 -
3d
González MA.Pattenden G. Angew. Chem. Int. Ed. 2003, 42: 1255 -
3e
Williams DR.Kiryanov AA.Emde U.Clark MP.Berliner MA.Reeves JT. Angew Chem. Int. Ed. 2003, 42: 1258 -
3f
Smith AB.Razler TM.Ciavarri JP.Hirose T.Ishikawa T. Org. Lett. 2005, 7: 4399 -
3g
Li DR.Zhang DH.Sun CY.Zhang JW.Yang L.Chen J.Liu B.Su C.Zhou WS.Lin GQ. Chemistry 2006, 12: 1185 -
4a
Forsyth CJ.Ying L.Chen J.La Clair JJ. J. Am. Chem. Soc. 2006, 128: 3858 -
4b
Uckun FM.Forsyth CJ. Bioorg. Med. Chem. Lett. 2001, 11: 1181 -
4c
Chen J.Ying L.Hansen TM.Engler MM.Lee CS.La Clain JJ.Forsyth CJ. Bioorg. Med. Chem. Lett. 2006, 16: 901 -
4d
Smith AB.Razler TM.Pettit GR.Chapuis J.-C. Org. Lett. 2005, 7: 4403 -
5a
Yadav JS.Rao CS.Chandrasekhar S.Ramarao AV. Tetrahedron Lett. 1995, 36: 7717 -
5b
Yadav JS.Abraham S.Reddy MM.Sabitha G.Sankar AR.Kunwar AC. Tetrahedron Lett. 2001, 42: 4713 -
5c
Yadav JS.Abraham S.Reddy MM.Sabitha G.Sankar AR.Kunwar AC. Tetrahedron Lett. 2002, 43: 3453 -
5d
Yadav JS.Md. Ahmed M. Tetrahedron Lett. 2002, 43: 7147 -
5e
Yadav JS.Reddy KB.Sabitha G. Tetrahedron Lett. 2004, 45: 6475 -
5f
Yadav JS.Srinivas R.Sathaiah K. Tetrahedron Lett. 2006, 47: 1603 - 6
Snider BB.Song F. Org. Lett. 2001, 3: 1817 -
7a
Bernsmann H.Gruner M.Fröhlich R.Metz P. Tetrahedron Lett. 2001, 42: 5377 -
7b
Klotz P.Mann A. Tetrahedron Lett. 2003, 44: 1927 - 8
Bolitt V.Mioskowski C.Kollah RO.Manna S.Rajapaksa D.Falck JR. J. Am. Chem. Soc. 1991, 113: 6320 - 10
Potman RP.Janssen NJML.Scheeren JW.Nivard RJF. J. Org. Chem. 1984, 49: 3628 - 11
Lafontaine JA.Provencal DP.Gardelli C.Leahy JW. J. Org. Chem. 2003, 68: 4215 - 12
Entwistle DA.Jordon SI.Montgomery J.Pattenden G. Synthesis 1998, 603 - 13
Mitsunobu O. Synthesis 1981, 1 -
14a
Baudin JB.Hareau G.Julia SA.Ruel O. Bull. Soc. Chim. Fr. 1993, 130: 336 -
14b
Baudin JB.Hareau G.Julia SA.Lorne R.Ruel O. Bull. Soc. Chim. Fr. 1993, 130: 856 - Review on modified Julia olefination:
-
14c
Blakemore PR. J. Chem. Soc., Perkin Trans. 1 2002, 2563
References and Notes
The six-membered ring is in the chair form 5C2 conformation. C1-H, C3-H and C5-H have axial orientations confirmed by NOE enhancement between C1-H/C5-H, C1-H/C3-H and C3-H/C5-H and also between C4-Me/C2-H (Figure [1] ). This arrangement is also strongly supported by the coupling constants J C1-H-C2-H = 10.57 Hz, J C3-H-C2-H = 10.57 Hz and J C3-H-C4-H = 4.53 Hz.
15
Spectral Data: Compound 1 [α]D +28.26 (c 0.01, CHCl3); 1H NMR (200 MHz, CDCl3): δ = 0.82 (d, J = 6.07 Hz, 3 H), 0.96 (d, J = 6.96 Hz, 3 H), 1.60-2.16 (m, 4 H) 1.87 (s, 3 H), 2.42 (s, 3 H), 3.24 (dd, J = 5.20, 10.41 Hz, 1 H), 3.44-3.76 (m, 3 H), 4.30-4.68 (m, 5 H), 6.10 (s, 1 H), 7.20-7.34 (m, 10 H), 7.38 (s, 1 H); 13C NMR (50 MHz, CDCl3): δ = 5.80, 13.23, 13.69, 18.72, 33.02, 33,38, 34.44, 67.03, 69.97, 72.95, 74.46, 76.28, 76.92, 77.56, 79.77, 83.99, 119.46, 127.44, 127.62, 128.26, 135.18, 137.24, 138.49, 138.67; LC-MS: m/z = 476 [M + H+].
Compound 10: [α]D +57.29 (c 1.85, CHCl3); 1H NMR (200 MHz, CDCl3): δ = 0.98 (d, J = 7.18 Hz, 3 H), 1.05 (d, J = 7.81 Hz, 3 H), 2.0-2.20 (m, 2 H), 2.25-2.36 (dd, J = 3.9, 15.6 Hz, 1 H), 2.57-2.70 (m, 1 H), 3.30 (s, 3 H), 3.68 (s, 3 H), 3.84 (m, 1 H), 4.25-4.34 (m, 1 H), 4.47-4.50 (m, 3 H), 7.22-7.30 (m, 5 H); 13C NMR (50 MHz, CDCl3): δ = 8.91, 12.89, 35.45, 36.60, 37.31, 51.53, 54.74, 67.34, 69.99, 75.36, 103.42, 127.03, 127.20, 128.14, 172.00; MS (FAB): m/z = 291 [M+- OMe].
Compound 13: colorless oil; [α]D +50.5 (c 1.00, CHCl3); IR (KBr): 3029, 2871, 1743 cm-1; 1H NMR (200 MHz, CDCl3): δ = 1.00 (d, J = 7.23 Hz, 3 H), 1.32 (d, J = 7.23 Hz, 3 H), 1.72-2.12 (m, 2 H), 2.24-2.40 (m, 1 H), 2.72-2.88 (m, 1 H), 3.52-3.72 (m, 2 H), 3.88 (t, J = 5.78 Hz, 1 H), 4.44-4.56 (m, 5 H), 7.24-7.36 (m, 10 H); 13C NMR (50 MHz, CDCl3): δ = 8.64, 12.57, 32.41, 35.56, 39.46, 66.24, 73.19, 73.56, 76.26, 127.44, 127.73, 128.40, 137.78, 138.15, 174.34; MS (FAB): m/z = 369 [M + H+].
Compound 14: colorless oil; [α]D +76.5 (c 1.00, CHCl3); 1H NMR (200 MHz, CDCl3): δ = 0.96 (d, J = 7.55, 3 H), 1.36 (d, J = 6.79 Hz, 3 H), 1.72-1.84 (m, 1 H), 1.96-2.08 (m 1 H), 2.24-2.32 (m, 1 H), 2.44-2.56 (m, 1 H), 3.48 (dd, J = 3.77, 9.82 Hz, 1 H), 3.54-3.60 (m, 2 H), 4.32-4.64 (m, 5 H), 7.24-7.32 (m, 10 H); 13C NMR (75 MHz, CDCl3): δ = 4.72, 14.61, 33.03, 38.31, 65.92, 70.56, 73.17, 76.15, 80.39, 127.61, 128.43, 137.59, 173.54; MS (FAB): m/z = 369 [M + H+].
Compound 16: colorless oil; [α]D +54.54 (c 0.01, CHCl3); IR (KBr): 2961, 2926, 2179 cm-1; 1H NMR (400 MHz, CDCl3): δ = 0.17 (s, 9 H), 0.96 (d, J = 6.79 Hz, 3 H), 1.04 (d, J = 6.79 Hz, 3 H), 1.56-1.68 (m, 1 H), 1.76-2.04 (m, 3 H), 3.09 (dd, J = 4.53, 10.57 Hz, 1 H), 3.46-3.60 (m, 2 H), 3.60-3.64 (d, J = 10.57 Hz, 1 H), 4.10 (q, J = 7.55, 14.35 Hz, 1 H), 4.30 (d, J = 11.33 Hz, 1 H), 4.49 (s, 2 H), 4.59 (d, J = 12.06 Hz, 1 H), 7.20-7.34 (m, 10 H); 13C NMR (50 MHz, CDCl3): δ = 5.99, 14.19, 33.33, 34.47, 37.23, 67.02, 69.96, 73.71, 75.98, 83.05, 103.65, 127.74, 128.44, 138.59; LC-MS: m/z = 450 [M + H+].
Compound 4: colorless oil; [α]D +90.0 (c 0.01, CHCl3); IR (KBr): 2969, 2926, 2858, 1718 cm-1; 1H NMR (400 MHz, CDCl3): δ = 0.84-0.98 (m, 6 H), 1.60-2.20 (m, 4 H), 2.11 (s, 3 H) 3.18 (dd, J = 4.68, 10.93 Hz, 1 H), 3.32 (d, J = 10.93 Hz, 1 H), 3.44-3.64 (m, 3 H), 4.32-4.70 (m, 4 H), 7.28 (m, 10 H); 13C NMR (75 MHz, CDCl3): δ = 6.98, 19.44, 26.51, 27.39, 28.40, 60.78, 64.133, 67.09, 69.16, 70.69, 71.11, 71.53, 77.26, 81.76, 121.69, 121.77, 122.44, 122.45, 132.39, 132.49, 201.15; LC-MS: m/z = 397 [M + H+].
Compound 5: IR (KBr): 3029, 2871, 1743 cm-1; 1H NMR (400 MHz, CDCl3): δ = 2.28 (s, 3 H), 4.71 (s, 2 H), 7.54-7.69 (m, 3 H), 7.99 (m, 1 H), 8.24 (m, 1 H); ESI-MS: m/z 295 [M + H+].